Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Manuela RobellaMarco VairaLuca AnsaloniSalvatore AseroStefano BacchettiFelice BorghiFrancesco CasellaFederico CoccoliniFranco De CianAndrea di GiorgioMassimo FramariniRoberta GelminiLuigina GraziosiShigeki KusamuraPiero LippolisRea Lo DicoAntonio MacrìDaniele MarrelliPaolo SammartinoCinzia SassaroliStefano ScaringiMarco TonelloMario ValleAntonio SommarivaPublished in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (2024)
The study concludes that Italian centers specialized in PSM treatment have limited adoption of ERAS protocols for CRS ± HIPEC, despite being aware of guidelines. The variability in practice highlights the need for standardized approaches and further evaluation of ERAS applicability in this complex surgical setting to optimize patient care.